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We describe an analytic approach to provide fine-scale 
discrimination among multiple infection source hypotheses. 
This  approach  uses  mutation-rate  data  for rapidly  evolv-
ing  multiple  locus  variable-number  tandem  repeat  loci  in 
probabilistic models to identify the most likely source. We 
illustrate the utility of this approach using data from a North 
American human plague investigation.
L
inking human disease events to likely sources of in-
fection has been advanced by molecular epidemiology. 
However, isolates from several potential infection sources 
often are similar, and none may exactly match the clini-
cal isolate genotype, especially if the methods used provide 
high  discrimination  (1).  Conclusions  from  partial-match 
genotypes are problematic but may provide the only data 
for  weighing  the  relative  importance  of  similar  source 
genotypes. Even perfect-match genotypes do not preclude 
partial-match sources as likely infection sources (2). We 
present a probabilistic approach based on mutation rates 
that can be used to identify the most likely source of infec-
tion. Our example is human plague, but the approach could 
be applied to other diseases for which data on marker muta-
tion rates are available (3).
Plague is caused by the bacterium Yersinia pestis. Be-
cause Y. pestis is an obligate pathogen that continuously 
cycles between rodents and fleas, mutations are generated 
regularly and can be observed among even closely related 
isolates (1). Human contact with infected fleas or rodents 
can result in human plague (4). Plague is rare in the United 
States, with <20 cases in 2006 (5) but is of concern because 
of the potential use of Y. pestis as a biological weapon (6). 
Thus, the ability to link a human plague isolate to a likely 
source has implications for investigating both natural dis-
ease and bioterrorism events.
Multiple locus variable-number tandem repeat (VNTR) 
analysis (MLVA) is useful for molecular epidemiologic 
studies  of  Y.  pestis  because  of  its  discrimination  power 
(1,7,8). We previously used MLVA to genotype the human 
isolate described below and queried the resulting genotype 
against a database containing genotypes from hundreds of 
Y. pestis isolates (9). This statistical approach identified 
isolates that most closely matched the human isolate and 
confirmed its most likely coarse geographic origin (north-
ern New Mexico). However, this set of near matches from 
the database query included isolates representing several 
different potential local infection sources, leaving the most 
likely fine-scale source unclear. The human and environ-
mental  isolates  were  indistinguishable  with  pulsed-field 
gel electrophoresis (PFGE); thus, the most likely fine-scale 
source could not be identified (10).
The Study
In  November  2002,  while  visiting  New  York,  New 
York, USA, 2 persons from Santa Fe County, New Mexico, 
USA, became ill with fever and unilateral inguinal adenopa-
thy; clinicians subsequently identified the illness as bubonic 
plague. Investigation by the New Mexico Department of 
Health and the Centers for Disease Control and Prevention 
indicated the patients were infected in New Mexico because 
Y.  pestis–positive  fleas  were  collected  near  the  patients’ 
home (10). However, because plague is endemic to the re-
gion, and flea samples from which isolates were obtained 
were collected at the home and along a local trail on which 
the patients hiked, either location could be the source. To 
identify the most likely fine-scale source of their infections, 
we examined specific mutations separating the human iso-
late from closely related environmental isolates.
We examined 5 Y. pestis isolates (Table 1) to develop 
a fine-scale spatial analysis of the infection. The reference 
isolate was obtained from 1 patient, 3 isolates were ob-
tained from fleas collected in the patients’ yard (9) (2 were 
collected before their illness as part of a long-term investi-
gation), and 1 isolate was obtained from the trail flea sam-
ples a short time later as part of the same long-term study 
(Figure 1). Other isolates were collected and examined but 
were excluded from this fine-scale analysis because they 
were more distinct from the human isolate, differing at >4 
VNTR loci. DNA extracts were prepared from each isolate 
(11,12) and analyzed using a 43-loci MLVA system as pre-
viously described (1,8).
We observed 3 MLVA genotypes (A–C) among the 5 
samples (Table 1, Figure 2). The human isolate was assigned 
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from the yard, differed from the reference by single-repeat 
mutations at 2 VNTR loci (M25 and M34; Figure 2, panel 
A). Genotype C, observed in 1 isolate from a flea obtained 
along the trail, also differed from the reference isolate at 
loci M25 and M34. However, the mutation at M25 was a 
double-repeat mutation that could be explained 2 ways: as 
a single 2-repeat mutational event (Figure 2, panel B) or 
as 2 sequential single-repeat mutations at the same locus 
(Figure 2, panel C). Although all 43 VNTR loci are useful 
for identifying the coarse geographic origin of an unknown 
isolate by using a database approach (9), our analysis ex-
amined only polymorphic loci because monomorphic loci 
provided no additional information. The molecular epide-
miologic  goal  was  to  identify  the  environmental  isolate 
most closely related to the human isolate and thus the most 
likely fine-scale geographic source of the infection.
To this end, we examined the relative probability of 
each mutation (Table 2) using published mutation rate data 
(1,8). We used mutation rate estimates for specific muta-
tional events to judge relative probabilities of different sce-
narios. This approach assumes 1) there is an intrinsic muta-
tion rate at each loci for each event, 2) we have accurately 
estimated these rates (1,8), and 3) we can use intrinsic rates 
to judge the relative likelihood of >2 hypotheses. We mul-
tiplied individual probabilities of mutations within a sce-
nario to calculate the overall relative probability (ORP) that 
an environmental isolate was related to the infection source 
(Table 2; Figure 2). To select the most likely source, we 
compared the ORP of each scenario with the others in a 
pairwise fashion (odds ratios, Table 2). In practice, only 
the most likely source needs to be compared with all other 
sources.
Conclusions
The patients most likely were infected from a source 
in their yard. Genotype B was observed in isolates from 
the yard, and this scenario had the highest ORP (7.9 × 10–9; 
hypothesis B→A; Table 2). The first scenario for genotype 
C (C1→A; Table 2) is second most likely (ORP 1.0 × 10–9). 
The odds ratio shows the most likely scenario (B→A) is 
just 7.9× more likely than this scenario (C1→A). These 2 
near matches illustrate the power of this approach: one is 
the most likely source, but the other is statistically possible 
because this odds ratio difference would not be significant 
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Table 1. Five Yersinia pestis isolates examined to determine the source of a human plague infection in New Mexico, USA* 
CDC isolate ID  Collection date  Collection source 
MLVA
genotype†  Flea source of Y. pestis isolate  Rodent source of flea 
NM024452 2002 Nov 5  Human A NA (human)  NA (human) 
NM02-1852-138  2002 Jul 17  Yard  B Orchopeas sexdentatus Neotoma micropus
NM02-1856-140  2002 Jul 18  Yard  B O. neotomae N. micropus
NM02-4477-309  2002 Nov 9  Yard  B Peromyscopsylla hesperomys Peromyscus leucopus
ED425 2003 Apr 4  Trail C O. sexdentatus N. micropus
*CDC, Centers for Disease Control and Prevention; ID, identification number; MLVA, multiple locus variable-number tandem repeat analysis; NA, not 
applicable. 
†See Figure 2. 
Figure 1. Distribution of rodent trapping stations along a hiking trail 
in Santa Fe County, New Mexico, USA. Each red circle indicates a 
single trapping site that had 3 traps. Trap stations (not shown) also 




ORP = 7.9 x 10–9 A
Human
M34:1 M25:2
Trail (genotype C, scenario 1)
ORP = 1.0 x 10–9 B
Human
M34:1 M25:1
Trail (genotype C, scenario 2)
ORP = 7.6 x 10–13 C M25:1
Figure  2.  Alternate  infection  source  hypotheses  for  the  plague 
cases in the persons who visited New York, New York, USA. Closed 
circles  indicate  genotypes;  black,  red,  and  blue  circles  indicate 
genotypes  A,  B,  and  C,  respectively.  Individual  mutations  are 
indicated as vertical lines on the comparisons and are labeled with 
the locus that mutated and the number of repeats involved in the 
mutations. Overall relative probabilities (ORP) based on Yersinia 
pestis mutation rates are presented for each comparison.Human Plague Infection
at α<0.05 (odds ratio >20). However, the ORP (1.0 × 104) 
for the second scenario for genotype C (C2→A; Table 2) 
would be statistically significant, enabling it to be rejected.
When  a  high-resolution  typing  approach  based  on 
loci with fast mutation rates, such as MLVA, is used, near 
matches should be the rule rather than the exception. After 
transmission, the pathogen will continue to propagate in 
environmental sources and in the patient, leading to addi-
tional mutations before investigators obtain isolates. Muta-
tions may also occur during routine laboratory procedures 
(e.g., culturing) before genotypic comparisons. Thus, per-
fect matches are rarely observed during phylogenetic anal-
ysis. Rather, the common ancestor (i.e., genotype of the 
source strain at time of infection) of the human isolate and 
each potential source isolate will need to be hypothesized. 
MLVA  and  probabilistic  modeling  provide  a  rigorous 
means to identify the most likely fine-scale environmental 
source. The same principles can be applied to other subtyp-
ing approaches used in investigations, including those with 
slower evolution patterns such as PFGE. In these cases, 
matches and near matches also should be judged by their 
relative evolutionary rates. Applying evolutionary proba-
bilistic modeling to subtyping will generate stronger con-
clusions by evaluating the relative strengths of alternative 
hypotheses regardless of the subtyping approach.
This  work  was  supported  by  the  National  Institutes  of 
Health–National  Institute  of  Allergy  and  Infectious  Diseases   
(grant 1R15AI070183), the Pacific-Southwest Regional Center 
of Excellence (AI065359), the Department of Homeland Security 
Science and Technology Directorate (contract no. HSHQDC-08-
C-00158), Achievement Rewards for College Scientists Founda-
tion Inc., and the Cowden Endowment at Northern Arizona Uni-
versity.
Ms Colman is completing her PhD degree in biological sci-
ences at the Center for Microbial Genetics and Genomics, North-
ern Arizona University. Her primary research interest is the ex-
amination of plague from evolutionary, ecological, and public 
health standpoints.
References
  1.  Girard JM, Wagner DM, Vogler AJ, Keys C, Allender CJ, Drickam-
er LC, et al. Differential plague-transmission dynamics determine 
Yersinia pestis population genetic structure on local, regional, and 
global scales. Proc Natl Acad Sci U S A. 2004;101:8408–13. DOI: 
10.1073/pnas.0401561101
  2.   Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, 
Persing DH, et al. Interpreting chromosomal DNA restriction pat-
terns produced by pulsed-field gel electrophoresis: criteria for bacte-
rial strain typing. J Clin Microbiol. 1995;33:2233–9.
  3.   Vogler AJ, Keys C, Nemoto Y, Colman RE, Jay Z, Keim P. Effect 
of repeat copy number on variable-number tandem repeat mutations 
in Escherichia coli O157:H7. J Bacteriol. 2006;188:4253–63. DOI: 
10.1128/JB.00001-06
  4.   Perry RD, Fetherston JD. Yersinia pestis—etiologic agent of plague. 
Clin Microbiol Rev. 1997;10:35–66.
  5.   Centers for Disease Control and Prevention. Human plague—four 
states, 2006. MMWR Morb Mortal Wkly Rep. 2006;55:940–3. 
  6.   Inglesby TV, Dennis DT, Henderson DA, Bartlett JG, Ascher MS, 
Eitzen E, et al. Plague as a biological weapon: medical and public 
health management. Working Group on Civilian Biodefense. JAMA. 
2000;283:2281–90. DOI: 10.1001/jama.283.17.2281
  7.   Pourcel C, Andre-Mazeaud F, Neubauer H, Ramisse F, Vergnaud G. 
Tandem repeats analysis for the high resolution phylogenetic analysis 
of Yersinia pestis. BMC Microbiol. 2004;4:22. DOI: 10.1186/1471-
2180-4-22
  8.   Vogler AJ, Keys CE, Allender C, Bailey I, Girard J, Pearson T, et al. 
Mutations, mutation rates, and evolution at the hypervariable VNTR 
loci of Yersinia pestis. Mutat Res. 2007;616:145–58.
  9.   Lowell JL, Wagner DM, Atshabar B, Antolin MF, Vogler AJ, Keim 
P, et al. Identifying sources of human exposure to plague. J Clin 
Microbiol. 2005;43:650–6. DOI: 10.1128/JCM.43.2.650-656.2005
10.   Centers for Disease Control and Prevention. Imported plague—New 
York City, 2002. MMWR Morb Mortal Wkly Rep. 2003;52:725–8.
11.   Allender CJ, Easterday WR, Van Ert MN, Wagner DM, Keim P. 
High-throughput extraction of arthropod vector and pathogen DNA 
using bead milling. Biotechniques. 2004;37:730, 732, 734.
12.   Keim P, Price LB, Klevytska AM, Smith KL, Schupp JM, Okinaka 
R, et al. Multiple-locus variable-number tandem repeat analysis re-
veals genetic relationships within Bacillus anthracis. J Bacteriol. 
2000;182:2928–36. DOI: 10.1128/JB.182.10.2928-2936.2000
Address  for  correspondence:  David  M.  Wagner,  Northern  Arizona 
University, Flagstaff, AZ 86011-5640, USA; email: dave.wagner@nau.
edu
  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 15, No. 10, October 2009  1625 
Table 2. Overall relative probabilities of isolates with genotypes B or C as the source of a human plague infection in New Mexico, 
USA* 
Rates of specific mutations between each genotype and 
genotype of the human isolate (A)† 
MLVA genotype  M34:1  M25:1  M25:2  Hypothesis 
Overall relative 
probability  OR‡ 
B (yard)  8.2 × 10
–5  9.7 × 10
–5  –  BĺA  7.9 × 10
–9  – 
C (trail, scenario 1)  8.2 × 10
–5  –  1.3 × 10
–5  C1ĺA  1.0 × 10
–9  7.9 
C (trail, scenario 2)  8.2 × 10
–5  (9.7 × 10
–5)
2  –  C2ĺA  7.6 × 10
–13  1.0 × 10
4 
*MLVA, multiple locus variable-number tandem repeat analysis; OR, odds ratio.  
†Values generated using data and approaches described in (8). 
‡The overall relative probability for each subsequent hypothesis is compared with the most likely hypothesis (BĺA). 
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